Search the LJMU website

Search results filters

1. Research confirms severity of COVID hazards for dentists

   New research has underlined the hazards associated with COVID-19 in dental surgery settings, and a solution to higher patient turnover.

2. Chartered Society of Forensic Sciences awards 2023 research grant to LJMU academic

   Dr Nick Dawnay from the School of Pharmacy and Biomolecular Sciences has been awarded a £10K in support of a project looking to develop eDNA methods to support wildlife forensic investigations.

3. Covid-19: Antiviral therapeutics from herbs

   Research finds natural proteins block SARS-CoV-2 from entering human cells

4. Professor Alison Ewing is announced as winner of the UKCPA Lifetime Achievement Award 2018

   The UK Clinical Pharmacy Association (UKCPA) recently presented their prestigious Lifetime Achievement Award for 2018 to Professor Alison Ewing.

5. Go ahead for new treatment for Black Bone Disease

   A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.

6. Vegan-based biomaterials developed to support eco-friendly crop management

   New vegan-based biomaterials could be used instead of chemical products and pesticides to help farmers manage their crops in a more eco-friendly and sustainable way, according to new research.

7. Scientific discoveries brought to a venue near you: Pint of Science Festival May 2025

   LJMU to participate for a third time in the global event that brings research to locations such as cafes and pubs.

8. Professor recognised with international pharmacology award

   Three decades of research excellence earn Professor honour at conference in India

9. Liverpool 'powerhouse' of drug development industry

   Liverpool School of Tropical Medicine, LJMU, the University of Liverpool and Edge Hill partner industry to speed up journey from laboratory to chemist.

10. Researchers developing aerosol vaccine against pneumonia

    LJMU's Formulation and Drug Delivery Research Group team up with the Butantan Institute in Brazil to test cheap, effective treatment